[go: up one dir, main page]

AU2003250547A1 - Cartilage differentiation inhibiting gene - Google Patents

Cartilage differentiation inhibiting gene

Info

Publication number
AU2003250547A1
AU2003250547A1 AU2003250547A AU2003250547A AU2003250547A1 AU 2003250547 A1 AU2003250547 A1 AU 2003250547A1 AU 2003250547 A AU2003250547 A AU 2003250547A AU 2003250547 A AU2003250547 A AU 2003250547A AU 2003250547 A1 AU2003250547 A1 AU 2003250547A1
Authority
AU
Australia
Prior art keywords
inhibiting gene
cartilage differentiation
differentiation inhibiting
cartilage
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003250547A
Inventor
Goichi Honda
Akio Matsuda
Shuji Muramatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2002228045A external-priority patent/JP2006166704A/en
Application filed by Asahi Kasei Corp, Asahi Chemical Industry Co Ltd filed Critical Asahi Kasei Corp
Publication of AU2003250547A1 publication Critical patent/AU2003250547A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2003250547A 2002-08-05 2003-08-05 Cartilage differentiation inhibiting gene Abandoned AU2003250547A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JPNO.2002-228045 2002-08-05
JP2002228045A JP2006166704A (en) 2002-08-05 2002-08-05 Cartilage differentiation inhibitory gene
US40177402P 2002-08-08 2002-08-08
US60/401,774 2002-08-08
PCT/JP2003/009939 WO2004013326A1 (en) 2002-08-05 2003-08-05 Cartilage differentiation inhibiting gene

Publications (1)

Publication Number Publication Date
AU2003250547A1 true AU2003250547A1 (en) 2004-02-23

Family

ID=31497635

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003250547A Abandoned AU2003250547A1 (en) 2002-08-05 2003-08-05 Cartilage differentiation inhibiting gene

Country Status (2)

Country Link
AU (1) AU2003250547A1 (en)
WO (1) WO2004013326A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009086952A2 (en) * 2008-01-07 2009-07-16 Projech Science To Technology, S.L. Compositions for the treatment of degenerative articular diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60043106D1 (en) * 1999-06-30 2009-11-19 Takeda Pharmaceutical POLYPEPTIDES AND THEIR DNA
CA2402735A1 (en) * 2000-03-13 2001-10-04 Incyte Genomics, Inc. Human transcription factors
US20020082206A1 (en) * 2000-05-30 2002-06-27 Leach Martin D. Novel polynucleotides from atherogenic cells and polypeptides encoded thereby
WO2003087375A1 (en) * 2002-04-16 2003-10-23 Asahi Kasei Pharma Corporation Cartilage differentiation regulating gene

Also Published As

Publication number Publication date
WO2004013326A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
AU2003225851A1 (en) Strong gene sets for glioma classification
AU2003228139A1 (en) Bioreactor
AU2003273640A1 (en) Autism gene
AU2003287300A1 (en) Identification of diet-regulated disease-associated genes
AU2003277516A1 (en) Continuous furnace
AU2002330401A1 (en) Gene overexpression system
AU2002327824A1 (en) Identification of snps the hgv-v gene
AU2003250547A1 (en) Cartilage differentiation inhibiting gene
AU2003294705A1 (en) NtSM GENE
AU2003267384A1 (en) Bhyd gene
AU2002953015A0 (en) Modified lacz gene
AU2003223121A1 (en) Cartilage differentiation regulating gene
AU2003302040A1 (en) Novel cancer-associated gene
AU2003277902A1 (en) Acc gene
AU2002306951A1 (en) Gene regulation ii
AU2003302457A1 (en) Mammalian prickle gene
AU2003241762A1 (en) Dna shuflling
AU2003244402A1 (en) Genetic markers for bone mass
AU2003281861A1 (en) Target dna
AU2003252991A1 (en) INTERFERON-Alpha INDUCED GENE
HK1069405A (en) Height-related gene
AU2002328863A1 (en) Oncosuppressive gene
HK1074222A (en) Marker gene
AU2002346709A1 (en) Cellulose-active microorganisms
AU2003241946A1 (en) Novel acylase gene